This compound helps eye cells make more of a natural 'clean-up' enzyme that fights harmful chemicals, but only if given early after stress begins.
Scientific Claim
Brosimine B at 10 µM is associated with a 124% increase in catalase enzyme activity in retinal cells after 3 hours of oxygen-glucose deprivation, suggesting enhancement of endogenous antioxidant defenses as a potential mechanism of protection.
Original Statement
“Treatment with 10 μM of Brosimine B caused a significant increase in catalase activity (124.00% ± 17.20%; Interaction 26.11, ***p < 0.001) compared to both the control and OGD groups (Figure 6A).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
While catalase activity is measured directly, the study cannot prove Brosimine B causes increased activity—it only shows association. 'Associated with' is correct for this design.
Evidence from Studies
Supporting (1)
Brosimine B and the biphasic dose-response: insights into hormesis and retinal neuroprotection
The study shows that a small amount of Brosimine B helps protect eye cells from damage during oxygen shortage by boosting their natural defense system, including an enzyme called catalase—even if it doesn’t give the exact 124% number, the overall idea is backed up.